EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma-Reference-Cited by-同舟云学术

EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma

Published:2006-07 Issue:7 Volume:100 Page:1152-1162
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Dahl Ronald,Chuchalin Alexander,Gor Dee,Yoxall Sally,Sharma Raj

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference16 articles.

1. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid;Greening;Lancet,1994

2. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids;Woolcock;Am J Respir Crit Care Med,1996

3. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma;van Noord;Thorax,1999

4. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group;Condemi;Ann Allergy Asthma Immunol,1999

5. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. National Institutes of Health, National Heart Lung and Blood Institute, 2002.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate–Severe Asthma: A Clinical Modelling and Simulation Study;Advances in Therapy;2024-09-06

2. Comparative Efficacy of Budesonide/Formoterol Versus Fluticasone/Salmeterol in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis;COPD: Journal of Chronic Obstructive Pulmonary Disease;2024-04-04

3. Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β2-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance and reliever therapy;Respiratory Medicine;2024-01

4. A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting β2-agonist plus short-acting β2 agonist reliever or maintenance and reliever therapy for asthma;Respiratory Medicine;2023-11

5. Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms;Advances in Therapy;2023-08-17